Prospective Asian Multicenter Prostate Cancer Focal Therapy Study (ProAMFocal)

Recruiting now

Conditions studied: Prostate Cancer

In brief

This is a multicenter observational study of patients undergoing focal therapy for prostate cancer in Asia

Key facts

Study ID

NCT06491056

Run by

Singapore General Hospital

People needed

500

Starts

2023-05-06

Expected to finish

2048-05-06

Last updated by the study team

2024-07-08

Who can join

Age: 40 and older, up to 85. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Prostate Adenocarcinoma
• Maximum Gleason score 4+4
• Maximum cancer volume 1.5 ml (up to 2 lesions) or 3 ml (single lesion)
• Maximum Prostate Specific Antigen (PSA) level 15 ng/dl
• Maximum clinical stage T2c
• American Society of Anesthesiologist Criteria 2 or less

You may not qualify if…

• Extra-prostatic Extension on multi parametric magnetic resonance imaging (mpMRI); capsular contact is permitted

Where it is running

• Singapore General Hospital — Singapore, Singapore (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.